Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade
Interferon gamma (IFNG/IFNγ)-induced adaptive immune resistance remains a challenge for tumor therapy. We observed that the chaperone heat shock protein 90 (HSP90) stabilizes the transcription factor signal transducer and activator of transcription 1 (STAT1), resulting in IFNγ-induced expression of...
Main Authors: | Jiao Liu, Rui Kang, Guido Kroemer, Daolin Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2022.2068488 |
Similar Items
-
CDK1/2/5 blockade: killing two birds with one stone
by: Jiao Liu, et al.
Published: (2021-01-01) -
Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
by: Mark R. Woodford, et al.
Published: (2016-02-01) -
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
by: David Escors, et al.
Published: (2022-10-01) -
Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies
by: Lindsey B. Shelton, et al.
Published: (2017-12-01) -
Functions and Therapeutic Potential of Extracellular Hsp60, Hsp70, and Hsp90 in Neuroinflammatory Disorders
by: Giusi Alberti, et al.
Published: (2021-01-01)